Generics 9

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lurasidone manufacturers

9 products found

Filters

lurasidone

Tablets, film coated 20 mg, 40 mg, 60 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Latuda
Manufacturer #252

Manufacturer usually replies in 4 days

lurasidone

Tablets, film coated 18.5 mg, 37.5 mg, 74 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #11864
A pharmaceutical manufacturer based in the EU that is active in 20+ countries worldwide selling its products in EU, CIS, LATAM, and South-East Asia for 30+ years. Key production lines are Rx medicines, OTC drugs, and dietary supplements with EU GMP certification. The company's main therapeutic areas include oncology, cardiology, psychiatry, and internal medicine. The company provides eCTD format dossiers as well as BE studies and stability studies.

Manufacturer usually replies in 7 days

lurasidone

Tablets, film coated 18.5 mg, 37 mg, 74 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Manufacturer #437

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

Want to see all 9 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Lurasidone is an antipsychotic medication used to treat schizophrenia and bipolar disorder. Suppliers of lurasidone market it in the form of oral tablets. Alternatives to it are other antipsychotic medications such as perospirone, risperidone, paliperidone, and iloperidone. The developer and earliest manufacturer of lurasidone medications was Sunovion Pharmaceuticals, which first introduced the drug into the market in 2010 under the trade name Latuda. It has since become approved in Canada and across the EU and has seen widespread use, with over 2 million prescriptions for it being registered annually in the U.S. alone. Lurasidone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified lurasidone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation